Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Zeitlinger

Showing results (311-320 of 352) with videos related to

Pageof 36
Sort By:
Molecular Pharmaceutics|September 6, 2018
Effect of Rifampicin on the Distribution of [<sup>11</sup>C]Erlotinib to the Liver, a Translational PET Study in Humans and in MiceMartin Bauer, Alexander Traxl, Akihiro Matsuda, et al.
Vaccine|April 6, 2012
Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccineHartmut J Ehrlich, Markus Müller, Herwig Kollaritsch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2019
Impact of P-Glycoprotein Function on the Brain Kinetics of the Weak Substrate <sup>11</sup>C-Metoclopramide Assessed with PET Imaging in HumansNicolas Tournier, Martin Bauer, Verena Pichler, et al.
Scientific Reports|April 28, 2024
A national evaluation analysis and expert interview study of real-world data sources for research and healthcare decision-makingVeronika Mikl, Dejan Baltic, Thomas Czypionka, et al.
Fluids and Barriers of the CNS|October 28, 2024
[<sup>11</sup>C]Metoclopramide PET can detect a seizure-induced up-regulation of cerebral P-glycoprotein in epilepsy patientsMyriam El Biali, Louise Breuil, Matthias Jackwerth, et al.
Clinical and Translational Science|May 3, 2024
St. John's wort extract with a high hyperforin content does not induce P-glycoprotein activity at the human blood-brain barrierMyriam El Biali, Michael Wölfl-Duchek, Matthias Jackwerth, et al.
The Lancet. Microbe|July 1, 2022
Research priorities towards precision antibiotic therapy to improve patient careZackery P Bulman, Sebastian G Wicha, Elisabet I Nielsen, et al.
The Journal of Antimicrobial Chemotherapy|March 28, 2024
Pharmacokinetics of isavuconazole at different target sites in healthy volunteers after single and multiple intravenous infusionsFelix Bergmann, Michael Wölfl-Duchek, Anselm Jorda, et al.
Clinical and Vaccine Immunology : CVI|April 18, 2014
Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patientsMaikel V W van der Velden, Alexander Geisberger, Thomas Dvorak, et al.
Antimicrobial Agents and Chemotherapy|July 21, 2022
Meropenem Population Pharmacokinetics and Simulations in Plasma, Cerebrospinal Fluid, and Brain TissueMohammad H Alshaer, Brooke Barlow, Nicole Maranchick, et al.
Pageof 36

Showing results (311-320 of 352) with videos related to

Sort By:
Pageof 36
Molecular Pharmaceutics|September 6, 2018
Effect of Rifampicin on the Distribution of [<sup>11</sup>C]Erlotinib to the Liver, a Translational PET Study in Humans and in MiceMartin Bauer, Alexander Traxl, Akihiro Matsuda, et al.
Vaccine|April 6, 2012
Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccineHartmut J Ehrlich, Markus Müller, Herwig Kollaritsch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2019
Impact of P-Glycoprotein Function on the Brain Kinetics of the Weak Substrate <sup>11</sup>C-Metoclopramide Assessed with PET Imaging in HumansNicolas Tournier, Martin Bauer, Verena Pichler, et al.
Scientific Reports|April 28, 2024
A national evaluation analysis and expert interview study of real-world data sources for research and healthcare decision-makingVeronika Mikl, Dejan Baltic, Thomas Czypionka, et al.
Fluids and Barriers of the CNS|October 28, 2024
[<sup>11</sup>C]Metoclopramide PET can detect a seizure-induced up-regulation of cerebral P-glycoprotein in epilepsy patientsMyriam El Biali, Louise Breuil, Matthias Jackwerth, et al.
Clinical and Translational Science|May 3, 2024
St. John's wort extract with a high hyperforin content does not induce P-glycoprotein activity at the human blood-brain barrierMyriam El Biali, Michael Wölfl-Duchek, Matthias Jackwerth, et al.
The Lancet. Microbe|July 1, 2022
Research priorities towards precision antibiotic therapy to improve patient careZackery P Bulman, Sebastian G Wicha, Elisabet I Nielsen, et al.
The Journal of Antimicrobial Chemotherapy|March 28, 2024
Pharmacokinetics of isavuconazole at different target sites in healthy volunteers after single and multiple intravenous infusionsFelix Bergmann, Michael Wölfl-Duchek, Anselm Jorda, et al.
Clinical and Vaccine Immunology : CVI|April 18, 2014
Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patientsMaikel V W van der Velden, Alexander Geisberger, Thomas Dvorak, et al.
Antimicrobial Agents and Chemotherapy|July 21, 2022
Meropenem Population Pharmacokinetics and Simulations in Plasma, Cerebrospinal Fluid, and Brain TissueMohammad H Alshaer, Brooke Barlow, Nicole Maranchick, et al.
Pageof 36